Lamictal Competitor Resource Kit

LAMICTAL

ARIPIPRAZOLE

LITHIUM

OLANZAPINE

QUETIAPINE

RISPERIDONE

SSRI

TOPIRAMATE

VALPROATE

ZIPRASIDONE

SSRI

SUPPORTING DATA

Marketing information
Key evidence
Supporting data
References

Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer


	1. Imipramine and paroxetine: bipolar depression 1 Authors: Nemeroff et al. Title: Double-blind, placebo-controlled comparison of imipramine and... 2. OFC in bipolar depression Author: Tohen, et al. Title: Efficacy of olanzapine and olanzapine/fluoxetine combination in... 3. Paroxetine versus second mood stabilizer Authors: Young et al. Title: Double-blind comparison of addition of a second mood stabilizer... 4. Mood stabilizers: antidepressant-induced switching Authors: Bottlender et al. Title: Mood-stablisers reduce the risk of developing... 5. Antidepressant-associated mania and hospitalization Authors: Preda et al. Title: Antidepressant-associated mania and psychosis resulting in... 6. Switch rates with 2nd-generation antidepressants Authors: Post RM, et al. Title: Rate of switch in bipolar patients prospectively... 7. Antidepressant-induced switch rates Authors: Serretti A et al. Title: Clinical features of antidepressant associated... 8. Paroxetine and switching Authors: Morishita S and Arita S. Title: Induction of mania in depression by... 9. SSRI combined with valproate or lithium Authors: Gyulai L, et al. Title: Maintenance efficacy of divalproex in the... 10. Switch rates in clinical practice Authors: Ghaemi SN, et al. Title: Is bipolar disorder still... Page 1 of 2